Overview
Good Clinical Practices (Health Canada) have evolved significantly with the adoption of ICH E6(R3) effective April 1, 2026. This modernization represents a shift toward risk-based, proportionate approaches to trial management and the integration of digital technologies. For professionals conducting modern clinical trials in Canada, understanding these updated requirements is essential for ensuring participant safety, data integrity, and regulatory compliance. This guide explores how Good Clinical Practices (Health Canada) apply to modern clinical trials and the training programs available to help you stay current.
The Evolution of Good Clinical Practices (Health Canada)
Good Clinical Practices (Health Canada) have undergone significant changes with the adoption of ICH E6(R3). Key updates include:
- Risk-based approaches – focusing resources on areas of highest risk to participant safety and data integrity
- Proportionate trial management – scaling activities according to trial complexity and risk
- Integration of digital technologies – embracing electronic data capture, remote monitoring, and digital health tools
- Decentralized and hybrid trial models – accommodating trials conducted outside traditional sites
- Expanded sponsor and investigator responsibilities – clarifying oversight and quality management expectations
How Good Clinical Practices (Health Canada) Support Modern Trial Designs
Good Clinical Practices (Health Canada) provide the regulatory framework for modern trial designs, including:
- Decentralized clinical trials – where participants are engaged remotely
- Hybrid trials – combining site-based and remote elements
- Digital health trials – incorporating wearable devices and mobile health technologies
- Adaptive trial designs – allowing for modifications based on interim data
Detailed Course Breakdown
Course 1: Good Clinical Practices (Health Canada)
This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) Good Clinical Practice (GCP) guideline.
Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026. It covers Health Canada regulatory requirements, sponsor and Qualified Investigator responsibilities, clinical trial application processes, informed consent, safety reporting, data governance, quality management, and inspection readiness.
Description of Modules: The curriculum covers:
- Health Canada regulatory requirements for clinical trials (Part C, Division 5)
- ICH E6(R3) Good Clinical Practice principles and Annex 1
- Sponsor, Qualified Investigator (QI), and Research Ethics Board (REB) responsibilities
- Clinical trial application (CTA) and amendment (CTA-A) processes
- Informed consent requirements and participant protection
- Safety reporting obligations (AEs, SAEs, SUSARs)
- Data governance and record keeping requirements
- Quality management and risk-based monitoring
- Investigational product management and GMP compliance
- Clinical trial inspections and enforcement
Target Audience:
- Sponsors (commercial and non-commercial/academic)
- Qualified Investigators (QIs) and Principal Investigators
- Sub-Investigators and clinical research staff
- Research Ethics Board (REB) members and administrators
- Clinical Research Coordinators and study site personnel
- Contract Research Organizations (CROs) and Service Providers
- Data managers and biostatisticians
- Clinical monitors and auditors
- Regulatory affairs professionals
- Quality assurance professionals
- Pharmacovigilance professionals
Pricing: Competitive pricing with group discounts available.
FAQ:
- How do Good Clinical Practices (Health Canada) support decentralized trials? Health Canada has adopted ICH E6(R3), which includes provisions for decentralized and hybrid trial elements.
- What is the role of digital technologies in modern GCP? ICH E6(R3) integrates digital technologies, including electronic data capture, remote monitoring, and digital health tools.
- How does risk-based monitoring work under Health Canada GCP? Risk-based approaches focus resources on areas of highest risk to participant safety and data integrity.
- What are the key changes in ICH E6(R3) for modern trials? Changes include risk-based approaches, proportionate trial management, and integration of digital technologies.
- How do I ensure my trial is compliant with Health Canada GCP? Complete updated GCP training aligned with ICH E6(R3) and stay current with regulatory guidance.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 2: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
- Clinical Trial Coordinators and Site Staff
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
- Clinical Research Organization (CRO) Personnel
Pricing: $149.00 with group discounts available.
FAQ:
- How does ICH E6(R3) support modern clinical trials? It provides a flexible, risk-based framework that accommodates diverse trial designs, including decentralized and hybrid models.
- What is the significance of risk-based approaches in GCP? Risk-based approaches enable efficient trial conduct by focusing resources on areas of highest risk.
- How do decentralized trials affect clinical research? They create new opportunities for participant engagement and data collection, supported by ICH E6(R3) provisions.
- What is the role of data governance in modern GCP? Data governance ensures the integrity, accuracy, and reliability of clinical trial data.
- How does ICH E6(R3) address digital technologies? It provides a framework for integrating digital health technologies, electronic data capture, and remote monitoring.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 3: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and technology vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- Why is HIPAA training important for modern clinical trials? Modern trials increasingly use digital technologies, requiring robust data privacy and security protections.
- What is Protected Health Information (PHI)? PHI is health information that identifies an individual or can be used to identify an individual.
- What is the difference between the HIPAA Privacy Rule and Security Rule? The Privacy Rule protects the privacy of PHI, while the Security Rule establishes standards for protecting ePHI.
- What is a breach under HIPAA? A breach is the unauthorized acquisition, access, use, or disclosure of PHI that compromises its security or privacy.
- How can I ensure HIPAA compliance in modern clinical trials? Compliance requires appropriate policies, training, technical safeguards, and oversight of business associates.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 4: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations with auditing practices based on ISO 19011:2026.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR
- Auditing Practices based on ISO 19011:2026
- Remote auditing methods including virtual audits
- Second-party auditing including supplier qualification
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
Pricing: $499.00 with group discounts available.
FAQ:
- What is the role of ISO 19011:2026 in GCP auditing? It provides the methodological framework for planning, conducting, reporting, and following up on audits.
- What are the key elements of audit programme management? Objectives, risks, resources, procedures, implementation, monitoring, review, and improvement.
- What is remote auditing and when is it used? Remote auditing uses virtual methods and technology to conduct audits, particularly useful for global trials.
- What is second-party auditing? Second-party auditing involves auditing suppliers, vendors, and service providers.
- What is the importance of auditor competence? Auditors must demonstrate personal behaviour, knowledge, skills, and maintain competence through ongoing evaluation.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management.
Description of Modules: The curriculum covers:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- How does regulatory affairs training support modern clinical trials? It provides the knowledge needed to navigate complex regulatory requirements for innovative trial designs.
- What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
- What is the eCTD format and why is it important? eCTD is the standard format for regulatory submissions.
- What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
- What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
